Technical Analysis for GOVX - GeoVax Labs, Inc.

Grade Last Price % Change Price Change
D 4.745 -1.15% -0.06
GOVX closed up 2.35 percent on Thursday, April 22, 2021, on 25 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical GOVX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish -1.15%
Wide Bands Range Expansion -1.15%
Crossed Above 20 DMA Bullish 1.17%
Outside Day Range Expansion 1.17%
Wide Bands Range Expansion 1.17%
Narrow Range Bar Range Contraction 6.63%
NR7 Range Contraction 6.63%
Wide Bands Range Expansion 6.63%
Down 3 Days in a Row Weakness 6.63%
Down 4 Days in a Row Weakness 6.63%
Older End-of-Day Signals for GOVX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance 25 minutes ago
Down 1% 25 minutes ago
Up 2% 25 minutes ago
Up 1% 25 minutes ago
Down 3% about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


GeoVax Labs, Inc. Description

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; U.S. Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; CaroGen Corporation; Virometix AG; U.S. Department of Defense; Geneva Foundation; Enesi Pharma; and Leidos, Inc. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Clinical Medicine Infectious Diseases Cancers Immunotherapies Hepatitis B Vaccine Department Of Defense Viruses Allergy HIV Immunodeficiency U.S. Department Of Defense Fever Virus Malaria Virology University Of Texas Ebola Chronic Hepatitis Leidos Scripps Zika Hiv Vaccine National Institute Of Allergy National Institute Of Allergy And Infectious Diseases Vaccinia

Is GOVX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 8.71
52 Week Low 0.22
Average Volume 1,251,857
200-Day Moving Average 3.10
50-Day Moving Average 5.22
20-Day Moving Average 4.64
10-Day Moving Average 4.85
Average True Range 0.60
ADX 29.95
+DI 32.80
-DI 12.76
Chandelier Exit (Long, 3 ATRs ) 4.38
Chandelier Exit (Short, 3 ATRs ) 5.71
Upper Bollinger Band 5.35
Lower Bollinger Band 3.93
Percent B (%b) 0.61
BandWidth 30.67
MACD Line -0.08
MACD Signal Line -0.10
MACD Histogram 0.0207
Fundamentals Value
Market Cap 66.33 Million
Num Shares 13.8 Million
EPS -5.62
Price-to-Earnings (P/E) Ratio -0.85
Price-to-Sales 4.33
Price-to-Book 0.00
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.51
Resistance 3 (R3) 5.49 5.25 5.39
Resistance 2 (R2) 5.25 5.07 5.25 5.35
Resistance 1 (R1) 5.02 4.96 5.14 5.04 5.31
Pivot Point 4.78 4.78 4.83 4.78 4.78
Support 1 (S1) 4.55 4.60 4.67 4.57 4.29
Support 2 (S2) 4.31 4.49 4.31 4.25
Support 3 (S3) 4.08 4.31 4.21
Support 4 (S4) 4.10